Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Zai Lab Limited < Previous 1 2 Next > Zai Lab to Present Preclinical Data of ZL-1503, an IL-13/IL-31 Bispecific Antibody for the Treatment of Atopic Dermatitis, at EADV Congress 2024 September 17, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab to Present Preliminary Data From Phase 1 Trial of ZL-1218, an Investigational Anti-CCR8 Antibody for the Treatment of Advanced Solid Tumors, at ESMO Congress 2024 August 27, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Announces Participation in September Investor Conferences August 22, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Announces Second Quarter 2024 Financial Results and Recent Corporate Updates August 06, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab and argenx Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China July 16, 2024 From Zai Lab Limited Via Business Wire Tickers ARGX ZLAB Zai Lab-Supported Study Published in Cell Provides New Insights with Potential to Improve Treatment of HRD-Positive Ovarian Cancers, Including Through Combination PARP Inhibitor and CCR8 Therapy July 15, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab to Announce Second Quarter 2024 Financial Results and Recent Corporate Updates on August 6, 2024 July 10, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Announces Dr. Harald Reinhart to Retire as Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases; Dr. Rafael Amado to be Appointed President, Head of Global R&D June 11, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Initiates Global Phase 2 Clinical Trial Evaluating ZL-1102 As a Topical Treatment for Chronic Plaque Psoriasis May 22, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam-Durlobactam or SUL-DUR) for Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Acinetobacter Baumannii-Calcoaceticus Complex in China May 20, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Announces Participation in May and June Investor Conferences May 16, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Announces Acceptance of Supplemental Biologics License Application with Priority Review for Efgartigimod Alfa Injection (Subcutaneous Injection) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China May 14, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Announces Approval of AUGTYRO™ (repotrectinib) for Patients with ROS1-positive NSCLC by China’s NMPA May 12, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates May 08, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024 April 15, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Statement on Executive Management Team’s Agreement on Share Activities April 11, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Presentations at AACR 2024 Annual Meeting to Showcase Ongoing Clinical Studies in Key Global Oncology Programs April 02, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic... April 01, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer March 27, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate (ADC) for Treatment of Solid Tumors March 13, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab to Present Final Overall Survival (OS) Data from Phase 3 NORA Study of ZEJULA (niraparib) in Platinum-Sensitive Recurrent Ovarian Cancer (PSROC) March 06, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Announces Participation in March Investor Conference March 06, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Announces Full-Year 2023 Financial Results and Recent Corporate Updates February 27, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab to Announce Full-Year 2023 Financial Results and Recent Corporate Updates on February 27, 2024 January 25, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Announces The New England Journal of Medicine Publication Demonstrating Durable Clinical Activity of Repotrectinib in Patients with Advanced ROS1 Fusion-Positive NSCLC January 10, 2024 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Announces Participation in January Investor Conference December 19, 2023 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Announces the First Listing of VYVGART® (efgartigimod alfa injection) and Other Updates in China’s National Reimbursement Drug List December 12, 2023 From Zai Lab Limited Via Business Wire Tickers ZLAB Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates November 07, 2023 From Zai Lab Limited Via GlobeNewswire Tickers ZLAB Zai Lab Announces Participation in November Investor Conferences October 26, 2023 From Zai Lab Limited Via GlobeNewswire Tickers ZLAB Zai Lab to Announce Third Quarter 2023 Financial Results and Recent Corporate Updates on November 7, 2023 October 18, 2023 From Zai Lab Limited Via GlobeNewswire Tickers ZLAB < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.